📰 4 sources covering this story

Wegovy-Maker Novo Nordisk Raises Full-Year Guidance - WSJ

First covered 3 hrs ago · latest take 33 mins ago. Compare how each outlet is covering it — and rate the sources you trust.

Wegovy-Maker Novo Nordisk Raises Full-Year Guidance - WSJ
Wegovy-Maker Novo Nordisk Raises Full-Year Guidance - WSJ
Wegovy-Maker Novo Nordisk Raises Full-Year Guidance  WSJ
Reuters
Reuters1 hrs ago
Novo outlook hike falls flat as high Wegovy pill hopes unmet
Novo outlook hike falls flat as high Wegovy pill hopes unmet  Reuters
Quartz
Quartz🏁 first to report3 hrs ago
Novo Nordisk is raising its full-year outlook as its weight loss pill keeps selling
The Danish drugmaker's Wegovy pill has exceeded 5 million prescriptions in the U.S. since launch, driving stronger-than-expected profit
Top rated outlets
Outlets are ranked once they have 3+ community ratings — be one of the first to rate.
🏆 Most trusted sources 2026 →
Scores come entirely from reader ratings — rate the sources you read to shape them. How it works →